60 mg retatrutide 60mg Pre-Filled Pen Weight Support Retatrutide Pen (30/40/60mg) | High
Description
Moreover, several studies have established a connection between the usage of Ozempic and more severe conditions such as gastroparesis

If you are ready to take control of your health, talk to your doctor to learn more about your weight loss options

A cross-sectional study revealed a potential association between DPP4 inhibitor use and an elevated risk of Hashimotos thyroiditis, psoriasis, and Crohns disease

The phase 3 TRIUMPH-4 data showed these rates at 9 mg and 12 mg doses respectively: Nausea: 38.1% and 43.2% (vs 10.7% placebo) Diarrhea: 34.7% and 33.1% (vs 13.4% placebo) Constipation: 21.8% and 25.0% (vs 8.7% placebo) Vomiting: 20.4% and 20.9% (vs placebo) These numbers are higher than cagrilintide monotherapy across the board

A separate and equally important counterpoint: a detailed 2026 evidence review published by Barbell Medicine found that GLP-1 medications do not appear to cause muscle loss beyond what matched caloric restriction produces on its own

Meanwhile, losing your smell has also been identified as an early sign of dementia
